Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.65
- Piotroski Score 3.00
- Grade N/A
- Symbol (GFR)
- Company Greenfire Resources Ltd
- Price $7.45
- Changes Percentage (-0.07%)
- Change -$0.01
- Day Low $7.39
- Day High $7.50
- Year High $8.03
Greenfire Resources Ltd., together with its subsidiaries, engages in the development, exploration, and operation of oil and gas properties in the Athabasca oil sands region of Alberta. The company operates the Tier-1 oil sands assets located in Western Canada. It utilizes steam-assisted gravity drainage (SAGD) extraction technology, a thermal oil recovery process to recover bitumen. The company is headquartered in Calgary, Canada.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/14/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.76
- Trailing P/E Ratio -3.31
- Forward P/E Ratio -3.31
- P/E Growth -3.31
- Net Income $-133,227,760
Income Statement
Quarterly
Annual
Latest News of GFR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
RYBREVANT® (amivantamab-vmjw) plus standard of care approved in the U.S. as first and only targeted regimen to cut risk of disease progression by more than half in second-line EGFR-mutated advanced lung cancer
The FDA approved RYBREVANT in combination with chemotherapy for EGFR-mutated NSCLC patients. Results from the Phase 3 MARIPOSA-2 study showed improved outcomes, making it the third new indication for ...
By Yahoo! Finance | 1 week ago -
Retail investors who hold 46% of Siegfried Holding AG (VTX:SFZN) gained 3.9%, institutions profited as well
Retail investors own 46% of Siegfried Holding AG, making them the most powerful group. Despite a recent stock price increase, institutions with 43% ownership also stand to gain. Analyzing shareholder ...
By Yahoo! Finance | 2 weeks ago -
RYBREVANT® (amivantamab-vmjw) plus chemotherapy shows positive overall survival trend versus chemotherapy in patients with previously treated EGFR-mutated lung cancer
Johnson & Johnson announced positive results from the Phase 3 MARIPOSA-2 study, showing RYBREVANT combined with chemotherapy led to significant and sustained improvement in post-progression outcomes f...
By Yahoo! Finance | 2 weeks ago